microRNA-378a-5p iS a novel positive regulator of melanoma progression
2020 · Oncogenesis · 47 citations
https://doi.org/10.1038/s41389-020-0203-6
E
Elisabetta Valentini
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
48
Papers
776
Citations
18
h-index
20
i10-index
Elisabetta Valentini is an academic researcher from University of Padua. The author has contributed to research in topics: Palliative Care and End-of-Life Issues & Cell death mechanisms and regulation & Protein Degradation and Inhibitors. The author has an h-index of 18, co-authored 41 publications.
ORCID: 0000-0003-3073-3590Papers by this author
worksSemaphorin 5A drives melanoma progression: role of Bcl-2, miR-204 and c-Myb
2018 · Journal of Experimental & Clinical Cancer Research · 23 citations
https://doi.org/10.1186/s13046-018-0933-x
Bcl-2 dependent modulation of Hippo pathway in cancer cells
2024 · Cell Communication and Signaling · 13 citations
https://doi.org/10.1186/s12964-024-01647-1
Bcl-2-like protein-10 increases aggressive features of melanoma cells
2022 · Exploration of Targeted Anti-tumor Therapy · 8 citations
https://doi.org/10.37349/etat.2022.00068
Semaphorin 5A modulates focal adhesion pathway and lamellipodia formation in melanoma
2025 · Cell Communication and Signaling · 0 citations
https://doi.org/10.1186/s12964-025-02526-z
Additional file 2 of PROTAC-mediated degradation of Bcl-xL potentiates target therapy in preclinical melanoma models
2026 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.31259911
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat